Cite
Nakatani K, Serada S, Fujimoto M, et al. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma. J Oral Pathol Med. 2021;doi: 10.1111/jop.13268.
Nakatani, K., Serada, S., Fujimoto, M., Obata, K., Ohkawara, T., Sasabe, E., Yamamoto, T., & Naka, T. (2021). Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma. Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology, . https://doi.org/10.1111/jop.13268
Nakatani, Kie, et al. "Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma." Journal of oral pathology & medicine : official publication of the International Association of Oral Pathologists and the American Academy of Oral Pathology vol. (2021). doi: https://doi.org/10.1111/jop.13268
Nakatani K, Serada S, Fujimoto M, Obata K, Ohkawara T, Sasabe E, Yamamoto T, Naka T. Gene therapy with SOCS1 induces potent preclinical antitumor activities in oral squamous cell carcinoma. J Oral Pathol Med. 2021 Dec 08; doi: 10.1111/jop.13268. Epub 2021 Dec 08. PMID: 34878693.
Copy
Download .nbib
